BMC chemistry

BMC Chem · ISSN (e) 2661-801X · 1 paper in corpus
article 2022
doi:10.1186/s13065-022-00849-3 ·PMID:35922841

Elagolix (ELX) is an orally administered non-peptidic GnRH antagonist that has been approved by the Food and Drug Administration in 2018 for the treatment of endometriosis pain. A sensitive and selective method for estimating elagolix (ELX)…